• Advance of molecular subtyping and precise treatment for gliomas
• Anaplastic astrocytoma
• Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms?
• Characteristics of gliomas in patients with somatic IDH mosaicism
• Determining chromosomal arms 1p/19q co-deletion status in low graded glioma by cross correlation-periodogram pattern analysis
• Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status
• Evaluation of the Oncomine Comprehensive Assay v3 panel for the detection of 1p/19q codeletion in oligodendroglial tumours
• Foundations of the Diagnosis and Management of Low-Grade Gliomas
• Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion
• Glioneuronal tumor with neuropil-like island: report of four cases and review of literature
• H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology
• Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion
• Interstitial deletions of chromosome 1p: novel 1p31.3p22.2 microdeletion in a newborn with craniosynostosis, coloboma and cleft palate, and review of the genomic and phenotypic profiles
• Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
• MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma
• Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography
• Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report
• Mutations of 1p genes do not consistently abrogate tumor suppressor functions in 1p-intact neuroblastoma
• Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion
• Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
• Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas
• Predicting 1p/19q co-deletion status from magnetic resonance imaging using deep learning in adult-type diffuse lower-grade gliomas: a discovery and validation study
• Recurrent oligodendroglioma with changed 1p/19q status
• Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification
• Segmentum: a tool for copy number analysis of cancer genomes
• Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution
• Static and dynamic ¹⁸F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status
• The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?
• Tumor cell-specific chromosomal abnormality in the vascular endothelial cells of anaplastic oligodendroglioma
• Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens